Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice

Molecular and Cellular Neuroscience

Volumn 31, Issue 2, 2006, Pages 293-302

  Borgkvist, Anders ^a   Puelles, Eduardo ^b,i   Carta, Manolo ^c   Acampora, Dario ^b,d,e   Ang, Siew Lan ^f   Wurst, Wolfgang ^g,h   Goiny, Michel ^a   Fisone, Gilberto ^a   Simeone, Antonio ^b,d,e   Usiello, Alessandro ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^f NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

ⁱ INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; PHOSPHOPROTEIN DARPP 32; TRANSCRIPTION FACTOR OTX2; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; EXPERIMENTAL MODEL; EXPLORATORY BEHAVIOR; FEMALE; MALE; MESENCEPHALON; MOTOR COORDINATION; MOUSE; MOUSE MUTANT; NERVE DEGENERATION; NEUROCHEMISTRY; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TRANSGENIC MOUSE; VENTRAL TEGMENTUM;

AMPHETAMINES; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; GENE SILENCING; HOMEODOMAIN PROTEINS; MALE; MESENCEPHALON; MICE; MORPHOGENESIS; MOTOR ACTIVITY; MUTATION; NEURONS; OTX TRANSCRIPTION FACTORS; RECEPTORS, DOPAMINE D1; ROTAROD PERFORMANCE TEST; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS MUSCULUS;

EID: 32244432674     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2005.09.018     Document Type: Article

References (53)

1. D. Acampora, S. Mazan, V. Avantaggiato, P. Barone, F. Tuorto, Y. Lallemand, P. Brulet, and A. Simeone Epilepsy and brain abnormalities in mice lacking the Otx1 gene Nat. Genet. 14 1996 218 222
2. D. Acampora, V. Avantaggiato, F. Tuorto, P. Briata, G. Corte, and A. Simeone Visceral endoderm-restricted translation of Otx1 mediates recovery of Otx2 requirements for specification of anterior neural plate and normal gastrulation Development 125 1998 5091 5104
3. D.L. Braff, and M.A. Geyer Sensorimotor gating and schizophrenia. Human and animal model studies Arch. Gen. Psychiatry 47 1990 181 188
4. P. Calabresi, D. Centonze, P. Gubellini, G.A. Marfia, A. Pisani, G. Sancesario, and G. Bernardi Synaptic transmission in the striatum: from plasticity to neurodegeneration Prog. Neurobiol. 61 2000 231 265
5. M.A. Cenci, I.Q. Whishaw, and T. Schallert Animal models of neurological deficits: how relevant is the rat? Nat. Rev., Neurosci. 3 2002 574 579
6. J.J. Clifford, A. Usiello, D. Vallone, A. Kinsella, E. Borrelli, and J.L. Waddington Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor Neuropharmacology 39 2000 382 390
7. L. Collin, A. Usiello, E. Erbs, C. Mathis, and E. Borrelli Motor training compensates for cerebellar dysfunctions caused by oligodendrocyte ablation Proc. Natl. Acad. Sci. U. S. A. 101 2004 325 330
8. J.N. Crawley, and R. Paylor A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice Horm. Behav. 31 1997 197 211
9. A. Dahlstrom, and K. Fuxe Evidence for the existence of monoamine-containing neurons in the central nervous system: I. Demonstration of monoamines in the cell bodies of brain stem neurons Acta Physiol. Scand. 62 Suppl. 232 1964 231 255
10. S. Denis-Donini, J. Glowinski, and A. Prochiantz Specific influence of striatal target neurons on the in vitro outgrowth of mesencephalic dopaminergic neurites: a morphological quantitative study J. Neurosci. 3 1983 2292 2299
11. H.C. Fibiger, and A.G. Phillips Mesocorticolimbic dopamine systems and reward Ann. N. Y. Acad. Sci. 537 1988 206 215
12. P. Foley, and P. Riederer Pathogenesis and preclinical course of Parkinson's disease J. Neural Transm., Suppl. 56 1999 31 74
13. C.R. Gerfen D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease Neuroscientist 9 2003 455 462
14. H.C. Hemmings Jr., and P. Greengard DARPP-32, a dopamine-regulated phosphoprotein Prog. Brain Res. 69 1986 149 159
15. O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function Pharmacol. Rev. 18 1966 925 964
16. S.E. Hyman, and R.C. Malenka Addiction and the brain: the neurobiology of compulsion and its persistence Nat. Rev., Neurosci. 2 2001 695 703
17. D.S. Kim, M.S. Szczypka, and R.D. Palmiter Dopamine-deficient mice are hypersensitive to dopamine receptor agonists J. Neurosci. 20 2000 4405 4413
18. R.A. Kimmel, D.H. Turnbull, V. Blanquet, W. Wurst, C.A. Loomis, and A.L. Joyner Two lineage boundaries coordinate vertebrate apical ectodermal ridge formation Genes Dev. 14 2000 1377 1389
19. D. Kirik, C. Rosenblad, and A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp. Neurol. 152 1998 259 277
20. M. Kobayashi, C. Iaccarino, A. Saiardi, V. Heidt, Y. Bozzi, R. Picetti, C. Vitale, H. Westphal, J. Drago, and E. Borrelli Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 11465 11470
21. G.F. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13 1992 177 184
22. R.M. Kostrzewa, T.A. Reader, and L. Descarries Serotonin neural adaptations to ontogenic loss of dopamine neurons in rat brain J. Neurochem. 70 1998 889 898
23. J.W. Langston, I. Irwin, E.B. Langston, and L.S. Forno 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra Neurosci. Lett. 48 1984 87 92
24. O. Lindvall, and A. Bjorklund Dopamine and norepinephrine containing neuron systems: their anatomy in the rat brain P.C. Emson Chemical Neuroanatomy 1983 Raven Press New York 229 255
25. K.L. McIlwain, M.Y. Merriweather, L.A. Yuva-Paylor, and R. Paylor The use of behavioral test batteries: effects of training history Physiol. Behav. 73 2001 705 717
26. G.J. Mogenson, D.L. Jones, and C.Y. Yim From motivation to action: functional interface between the limbic system and the motor system Prog. Neurobiol. 14 1980 69 97
27. A.E. Moore, F. Cicchetti, J. Hennen, and O. Isacson Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat Exp. Neurol. 172 2001 363 376
28. I. Nunes, L.T. Tovmasian, R.M. Silva, R.E. Burke, and S.P. Goff Pitx3 is required for development of substantia nigra dopaminergic neurons Proc. Natl. Acad. Sci. U. S. A. 100 2003 4245 4250
29. C.W. Olanow, and W.G. Tatton Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci. 22 1999 123 144
30. F.E. Pontieri, G. Tanda, and G. Di Chiara Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens Proc. Natl. Acad. Sci. U. S. A. 92 1995 12304 12308
31. E. Puelles, D. Acampora, E. Lacroix, M. Signore, A. Annino, F. Tuorto, S. Filosa, G. Corte, W. Wurst, S.L. Ang, and A. Simeone Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain Nat. Neurosci. 6 2003 453 460
32. E. Puelles, A. Annino, F. Tuorto, A. Usiello, D. Acampora, T. Czerny, C. Brodski, S.L. Ang, W. Wurst, and A. Simeone Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain Development 131 2004 2037 2048
33. P. Riederer, and S. Wuketich Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis J. Neural Transm. 38 1976 277 301
34. J.D. Salamone, M.J. Zigmond, and E.M. Stricker Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions Neuroscience 39 1990 17 24
35. D.W. Self, and E.J. Nestler Molecular mechanisms of drug reinforcement and addiction Annu. Rev. Neurosci. 18 1995 463 495
36. A. Simeone Detection of mRNA in tissue sections with radiolabelled riboprobes D.G. Wilkinson In Situ Hybridization: A Practical Approach 1998 Oxford University Press Oxford 69 86
37. A. Simeone, E. Puelles, and D. Acampora The Otx family Curr. Opin. Genet. Dev. 12 2002 409 415
38. M.P. Smidt, S.M. Smits, H. Bouwmeester, F.P. Hamers, A.J. van der Linden, A.J. Hellemons, J. Graw, and J.P. Burbach Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3 Development 131 2004 1145 1155
39. G.L. Snyder, J.A. Girault, J.Y. Chen, A.J. Czernik, J.W. Kebabian, J.A. Nathanson, and P. Greengard Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine J. Neurosci. 12 1992 3071 3083
40. P. Svenningsson, A. Nishi, G. Fisone, J.A. Girault, A.C. Nairn, and P. Greengard DARPP-32: an integrator of neurotransmission Annu. Rev. Pharmacol. Toxicol. 44 2004 269 296
41. U. Ungerstedt Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system Acta Physiol. Scand., Suppl. 367 1971 95 122
42. U. Ungerstedt Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system Acta Physiol. Scand., Suppl. 367 1971 69 93
43. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
44. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol. Rev. 94 1987 469 492
45. R.A. Wise, and D.C. Hoffman Localization of drug reward mechanisms by intracranial injections Synapse 10 1992 247 263
46. W. Wurst, A.B. Auerbach, and A.L. Joyner Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum Development 120 1994 2065 2075
47. I. Yamazoe, Y. Takeuchi, H. Matsushita, and T. Sawada Serotonergic heterotypic sprouting in the unilaterally dopamine-depleted mouse neostriatum Dev. Neurosci. 23 2001 78 83
48. Q.Y. Zhou, and R.D. Palmiter Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic Cell 83 1995 1197 1209
49. M.J. Zigmond, and E.M. Stricker Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats Science 177 1972 1211 1214
50. M.J. Zigmond, and E.M. Stricker Animal models of parkinsonism using selective neurotoxins: clinical and basic implications Int. Rev. Neurobiol. 31 1989 1 79
51. M.J. Zigmond, A.L. Acheson, M.K. Stachowiak, and E.M. Stricker Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism Arch. Neurol. 41 1984 856 861
52. A. Zuddas, G.U. Corsini, S. Schinelli, J.N. Johannessen, U. di Porzio, and I.J. Kopin MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra Brain Res. 501 1989 1 10
53. A. Zuddas, G.U. Corsini, J.L. Barker, I.J. Kopin, and U. di Porzio Specific reinnervation of lesioned mouse striatum by grafted mesencephalic dopaminergic neurons Eur. J. Neurosci. 1 1991 72 85 (Oct 3)